Works matching DE "VACCINE immunogenicity"

Results: 562
    1
    2
    3
    4
    5

    СТАНДАРТИЗАЦИЯ ИММУНОГЕННОСТИ ИНАКТИВИРОВАННОЙ ВАКЦИНЫ QAZVAC ПРОТИВ КОРОНАВИРУСНОЙ ИНФЕКЦИИ COVID-19 ИЗ ЭПИДЕМИОЛОГИЧЕСКИ АКТУАЛЬНОГО ШТАММА.

    Published in:
    Eurasian Journal of Applied Biotechnology, 2023, n. 4, p. 31
    By:
    • Б. Ш., Мырзахметова;
    • Г. А., Жаппарова;
    • К. Б., Бисенбаева;
    • А. С., Тойтанова;
    • М. С., Туысканова;
    • Г. Д., Наханова;
    • С. Ш., Нурабаев;
    • К. Д., Жугунисов;
    • Л. Б., Кутумбетов
    Publication type:
    Article
    6
    7
    8

    Immunogenicity of SARS-CoV-2 Vaccination Schedules Including a Booster Dose in Patients with Systemic Lupus Erythematosus: Data from a Prospective Multicenter Study.

    Published in:
    Vaccines, 2025, v. 13, n. 2, p. 127, doi. 10.3390/vaccines13020127
    By:
    • Sartori, Natália Sarzi;
    • Machado, Ketty Lysie Libardi Lira;
    • Miyamoto, Samira Tatiyama;
    • Pretti, Flávia Zon;
    • Gouveia, Maria da Penha Gomes;
    • de Oliveira, Yasmin Gurtler Pinheiro;
    • da Silva, Vanezia Gonçalves;
    • Faé, Filipe;
    • Burian, Ana Paula Neves;
    • Tapia, Karina Rosemarie Lallemand;
    • Moulin, Anna Carolina Simões;
    • Grillo, Luiza Lorenzoni;
    • Athayde, Paula dos Santos;
    • Corona, Helena da Silva;
    • Ramos, Sabrina de Souza;
    • Peixoto, Flávia Maria Matos Melo Campos;
    • Ribeiro, Priscila Dias Cardoso;
    • Magalhães, Vanessa de Oliveira;
    • de Aguiar, Mariana Freitas;
    • Biegelmeyer, Erika
    Publication type:
    Article
    9
    10

    COVID-19 Breakthrough Infections in Immune-Mediated Inflammatory Diseases: Data from the SUCCEED (Safety and Immunogenicity of COVID-19 Vaccines in Systemic Autoimmune-Mediated Inflammatory Diseases) Study.

    Published in:
    Vaccines, 2025, v. 13, n. 2, p. 104, doi. 10.3390/vaccines13020104
    By:
    • Tan, Jeremiah;
    • Bernatsky, Sasha;
    • Lee, Jennifer L. F.;
    • Fortin, Paul R.;
    • Dayam, Roya M.;
    • Gingras, Anne-Claude;
    • Colmegna, Ines;
    • Bowdish, Dawn M. E.;
    • Berger, Claudie;
    • Chan, Dora;
    • Larché, Maggie J.;
    • Richards, Dawn P.;
    • Gonzalez Arreola, Lourdes;
    • Hitchon, Carol A.;
    • Lalonde, Nadine;
    • Aviña-Zubieta, J. Antonio
    Publication type:
    Article
    11
    12
    13

    Immunogenicity of SARS-CoV-2 Vaccination Schedules Including a Booster Dose in Patients with Systemic Lupus Erythematosus: Data from a Prospective Multicenter Study.

    Published in:
    Vaccines, 2025, v. 13, n. 2, p. 127, doi. 10.3390/vaccines13020127
    By:
    • Sartori, Natália Sarzi;
    • Machado, Ketty Lysie Libardi Lira;
    • Miyamoto, Samira Tatiyama;
    • Pretti, Flávia Zon;
    • Gouveia, Maria da Penha Gomes;
    • de Oliveira, Yasmin Gurtler Pinheiro;
    • da Silva, Vanezia Gonçalves;
    • Faé, Filipe;
    • Burian, Ana Paula Neves;
    • Tapia, Karina Rosemarie Lallemand;
    • Moulin, Anna Carolina Simões;
    • Grillo, Luiza Lorenzoni;
    • Athayde, Paula dos Santos;
    • Corona, Helena da Silva;
    • Ramos, Sabrina de Souza;
    • Peixoto, Flávia Maria Matos Melo Campos;
    • Ribeiro, Priscila Dias Cardoso;
    • Magalhães, Vanessa de Oliveira;
    • de Aguiar, Mariana Freitas;
    • Biegelmeyer, Erika
    Publication type:
    Article
    14
    15

    COVID-19 Breakthrough Infections in Immune-Mediated Inflammatory Diseases: Data from the SUCCEED (Safety and Immunogenicity of COVID-19 Vaccines in Systemic Autoimmune-Mediated Inflammatory Diseases) Study.

    Published in:
    Vaccines, 2025, v. 13, n. 2, p. 104, doi. 10.3390/vaccines13020104
    By:
    • Tan, Jeremiah;
    • Bernatsky, Sasha;
    • Lee, Jennifer L. F.;
    • Fortin, Paul R.;
    • Dayam, Roya M.;
    • Gingras, Anne-Claude;
    • Colmegna, Ines;
    • Bowdish, Dawn M. E.;
    • Berger, Claudie;
    • Chan, Dora;
    • Larché, Maggie J.;
    • Richards, Dawn P.;
    • Gonzalez Arreola, Lourdes;
    • Hitchon, Carol A.;
    • Lalonde, Nadine;
    • Aviña-Zubieta, J. Antonio
    Publication type:
    Article
    16
    17

    Safety and Immunogenicity of the Tetravalent Recombinant COVID-19 Protein Vaccine SCTV01E in Children and Adolescents Aged 3 to 17 Years: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Trial.

    Published in:
    Vaccines, 2025, v. 13, n. 1, p. 43, doi. 10.3390/vaccines13010043
    By:
    • Zhu, Fengcai;
    • Huang, Ting;
    • Jin, Pengfei;
    • Zhang, Linglin;
    • Jin, Zhongqiang;
    • Zhang, Wenli;
    • Yuan, Dongya;
    • Wang, Zhong;
    • Deng, Yusong;
    • Li, Jiaxin;
    • Shen, Xiao;
    • Fu, Yongpan;
    • Li, Jian;
    • Yang, Xinjie;
    • Li, Jing;
    • Xie, Liangzhi
    Publication type:
    Article
    18
    19

    Newcastle Disease Virus Displaying an Ectodomain of Middle East Respiratory Syndrome Coronavirus Spike Protein Elicited Robust Humoral and Cellular Immunity in Mice.

    Published in:
    Vaccines, 2025, v. 13, n. 1, p. 2, doi. 10.3390/vaccines13010002
    By:
    • Prasopsiri, Jaturawitt;
    • Srisutthisamphan, Kanjana;
    • Liwnaree, Benjamas;
    • Jengarn, Juggragarn;
    • Kramyu, Jarin;
    • Hansoongnern, Payuda;
    • Muangsanit, Papon;
    • Tanwattana, Nathiphat;
    • Kaewborisuth, Challika;
    • Sungsuwan, Suttipun;
    • Jongkaewwattana, Anan;
    • Wanasen, Nanchaya
    Publication type:
    Article
    20

    Development, Pre-Clinical Safety, and Immune Profile of RENOVAC—A Dimer RBD-Based Anti-Coronavirus Subunit Vaccine.

    Published in:
    Vaccines, 2024, v. 12, n. 12, p. 1420, doi. 10.3390/vaccines12121420
    By:
    • Muminov, Muzaffar;
    • Tsiferova, Nargiza;
    • Pshenichnov, Egor;
    • Ermatova, Khusnora;
    • Charishnikova, Oksana;
    • Abdullaev, Alisher;
    • Levitskaya, Yuliya;
    • Dalimova, Dilbar;
    • MVS, Sandhya;
    • Tomar, Geetanjali;
    • Dewle, Ankush;
    • Choudhari, Pradhnya;
    • Wangikar, Aditi;
    • Jadhav, Amol;
    • Mule, Mrunal;
    • Wangikar, Pralhad;
    • Abdurakhmonov, Ibrokhim;
    • Turdikulova, Shahlo
    Publication type:
    Article
    21

    An Inactivated West Nile Virus Vaccine Candidate Based on the Lineage 2 Strain.

    Published in:
    Vaccines, 2024, v. 12, n. 12, p. 1398, doi. 10.3390/vaccines12121398
    By:
    • Vorovitch, Mikhail F.;
    • Tuchynskaya, Ksenia K.;
    • Kruglov, Yuriy A.;
    • Peunkov, Nikita S.;
    • Mostipanova, Guzal F.;
    • Kholodilov, Ivan S.;
    • Ivanova, Alla L.;
    • Fedina, Maria P.;
    • Gmyl, Larissa V.;
    • Morozkin, Evgeny S.;
    • Roev, German V.;
    • Karan, Lyudmila S.;
    • Karganova, Galina G.
    Publication type:
    Article
    22
    23
    24
    25
    26
    27
    28
    29

    STAR LIGHT Study: XBB.1.5 COVID-19 mRNA Vaccines Boost Systemic but Not Mucosal Immunity Against the SARS-CoV-2 JN.1 Variant in Patients with Chronic Liver Disease.

    Published in:
    Vaccines, 2024, v. 12, n. 11, p. 1241, doi. 10.3390/vaccines12111241
    By:
    • Woelfel, Simon;
    • Junker, Daniel;
    • Bergamin, Irina;
    • Meyer-Herbon, Pamela;
    • Stillhard, Roman;
    • Graf, Nicole;
    • Leinenkugel, Georg;
    • Dütschler, Joel;
    • König, Marius;
    • Kammerlander, Livia;
    • Häuptle, Rahel;
    • Zwyssig, Sarah;
    • Krieger, Claudia;
    • Truniger, Samuel;
    • Koller, Seraina;
    • Metzger-Peter, Katline;
    • Frei, Nicola;
    • Albrich, Werner C.;
    • Friedrich, Matthias;
    • Bernsmeier, Christine
    Publication type:
    Article
    30

    Immunogenicity and Efficacy of Combined mRNA Vaccine Against Influenza and SARS-CoV-2 in Mice Animal Models.

    Published in:
    Vaccines, 2024, v. 12, n. 11, p. 1206, doi. 10.3390/vaccines12111206
    By:
    • Mazunina, Elena P.;
    • Gushchin, Vladimir A.;
    • Bykonia, Evgeniia N.;
    • Kleymenov, Denis A.;
    • Siniavin, Andrei E.;
    • Kozlova, Sofia R.;
    • Mukasheva, Evgenya A.;
    • Shidlovskaya, Elena V.;
    • Kuznetsova, Nadezhda A.;
    • Usachev, Evgeny V.;
    • Zlobin, Vladimir I.;
    • Burtseva, Elena I.;
    • Ivanov, Roman A.;
    • Logunov, Denis Y.;
    • Gintsburg, Alexander L.
    Publication type:
    Article
    31
    32

    Immunogenicity and Protectivity of Sputnik V Vaccine in hACE2-Transgenic Mice against Homologous and Heterologous SARS-CoV-2 Lineages Including Far-Distanced Omicron BA.5.

    Published in:
    Vaccines, 2024, v. 12, n. 10, p. 1152, doi. 10.3390/vaccines12101152
    By:
    • Dolzhikova, Inna V.;
    • Tukhvatulin, Amir I.;
    • Grousova, Daria M.;
    • Zorkov, Ilya D.;
    • Komyakova, Marina E.;
    • Ilyukhina, Anna A.;
    • Kovyrshina, Anna V.;
    • Shelkov, Artem Y.;
    • Botikov, Andrey G.;
    • Samokhvalova, Ekaterina G.;
    • Reshetnikov, Dmitrii A.;
    • Siniavin, Andrey E.;
    • Savina, Daria M.;
    • Shcheblyakov, Dmitrii V.;
    • Izhaeva, Fatima M.;
    • Dzharullaeva, Alina S.;
    • Erokhova, Alina S.;
    • Popova, Olga;
    • Ozharovskaya, Tatiana A.;
    • Zrelkin, Denis I.
    Publication type:
    Article
    33
    34
    35
    36
    37
    38

    Safety and Immunogenicity of a Carbohydrate Fatty Acid Monosulphate Ester Adjuvant Combined with a Low-Dose Quadrivalent Split-Virion Inactivated Influenza Vaccine: A Randomised, Observer-Blind, Active-Controlled, First-in-Human, Phase 1 Study.

    Published in:
    Vaccines, 2024, v. 12, n. 9, p. 1036, doi. 10.3390/vaccines12091036
    By:
    • D'Onofrio, Valentino;
    • Porrez, Sharon;
    • Jacobs, Bart;
    • Alhatemi, Azhar;
    • De Boever, Fien;
    • Waerlop, Gwenn;
    • Michels, Els;
    • Vanni, Francesca;
    • Manenti, Alessandro;
    • Leroux-Roels, Geert;
    • Platenburg, Peter Paul;
    • Hilgers, Luuk;
    • Leroux-Roels, Isabel
    Publication type:
    Article
    39

    Predictors of Hospitalization in Breakthrough COVID-19 among Fully Vaccinated Individuals with Immune-Mediated Rheumatic Diseases: Data from SAFER-Study.

    Published in:
    Vaccines, 2024, v. 12, n. 9, p. 1031, doi. 10.3390/vaccines12091031
    By:
    • Calderaro, Débora Cerqueira;
    • Valim, Valéria;
    • Ferreira, Gilda Aparecida;
    • Machado, Ketty Lysie Libardi Lira;
    • Ribeiro, Priscila Dias Cardoso;
    • Ribeiro, Sandra Lúcia Euzébio;
    • Sartori, Natalia Sarzi;
    • de Rezende, Rodrigo Poubel Vieira;
    • de Melo, Ana Karla Guedes;
    • Cruz, Vitor Alves;
    • Vieira, Adah Sophia Rodrigues;
    • Kakehasi, Adriana Maria;
    • de Landa, Aline Teixeira;
    • Burian, Ana Paula Neves;
    • Peixoto, Flávia Maria Matos Melo Campos;
    • Telles, Camila Maria Paiva França;
    • do Espírito Santo, Rafaela Cavalheiro;
    • Baptista, Katia Lino;
    • de Oliveira, Yasmin Gurtler Pinheiro;
    • Magalhães, Vanessa de Oliveira
    Publication type:
    Article
    40
    41

    Safety and Immunogenicity of the Intranasal Vaccine Candidate Mambisa and the Intramuscular Vaccine Abdala Used as Booster Doses for COVID-19 Convalescents: A Randomized Phase 1–2 Clinical Trial.

    Published in:
    Vaccines, 2024, v. 12, n. 9, p. 1001, doi. 10.3390/vaccines12091001
    By:
    • Lemos-Pérez, Gilda;
    • Barrese-Pérez, Yinet;
    • Chacón-Quintero, Yahima;
    • Uranga-Piña, Rolando;
    • Avila-Albuerne, Yisel;
    • Figueroa-García, Iglermis;
    • Calderín-Marín, Osaida;
    • Gómez-Vázquez, Martha M.;
    • Piñera-Martínez, Marjoris;
    • Chávez-Valdés, Sheila;
    • Martínez-Rosales, Ricardo;
    • Ávila-Díaz, Lismary;
    • Vázquez-Arteaga, Amalia;
    • González-Formental, Hany;
    • Freyre-Corrales, Giselle;
    • Coizeau-Rodríguez, Edelgis;
    • Limonta-Fernández, Miladys;
    • Ayala-Avila, Marta;
    • Martínez-Díaz, Eduardo;
    • Pimentel-Vazquez, Eulogio
    Publication type:
    Article
    42
    43
    44
    45

    Long-Term Safety and Immunogenicity of AZD1222 (ChAdOx1 nCoV-19): 2-Year Follow-Up from a Phase 3 Study.

    Published in:
    Vaccines, 2024, v. 12, n. 8, p. 883, doi. 10.3390/vaccines12080883
    By:
    • Shoemaker, Kathryn;
    • Soboleva, Karina;
    • Branche, Angela;
    • Shankaran, Shivanjali;
    • Theodore, Deborah A.;
    • Bari, Muhammad;
    • Ezeh, Victor;
    • Green, Justin;
    • Kelly, Elizabeth;
    • Lan, Dongmei;
    • Olsson, Urban;
    • Saminathan, Senthilkumar;
    • Shankar, Nirmal Kumar;
    • Villegas, Berta;
    • Villafana, Tonya;
    • Falsey, Ann R.;
    • Sobieszczyk, Magdalena E.
    Publication type:
    Article
    46

    Boost and Increased Antibody Breadth Following a Second Dose of PARVAX for SARS-CoV-2 in Mice and Nonhuman Primates.

    Published in:
    Vaccines, 2024, v. 12, n. 8, p. 882, doi. 10.3390/vaccines12080882
    By:
    • Bhatt, Urja;
    • Herate, Cecile;
    • Estelien, Reynette;
    • Relouzat, Francis;
    • Dereuddre-Bosquet, Nathalie;
    • Maciorowski, Dawid;
    • Diop, Cheikh;
    • Couto, Emma;
    • Staiti, Jillian;
    • Cavarelli, Mariangela;
    • Bossevot, Laëtitia;
    • Sconosciuti, Quentin;
    • Bouchard, Page;
    • Le Grand, Roger;
    • Vandenberghe, Luk H.;
    • Zabaleta, Nerea
    Publication type:
    Article
    47
    48

    PREVAX: A Phase I Clinical Trial of an EGF-Based Vaccine in Moderate-to-Severe COPD Patients.

    Published in:
    Vaccines, 2024, v. 12, n. 8, p. 833, doi. 10.3390/vaccines12080833
    By:
    • Hernandez Reyes, Jenysbel de la C.;
    • Santos Morales, Orestes;
    • Hernandez Moreno, Laura;
    • Pino Alfonso, Pedro Pablo;
    • Neninger Vinageras, Elia;
    • Knigths Montalvo, Julia Lilliam;
    • Aguilar Sosa, Aliuska;
    • Gonzalez Morera, Amnely;
    • Lorenzo-Luaces Alvárez, Patricia;
    • Aguilar Venegas, Yadira;
    • Troche Concepción, Mayelin;
    • Medel Pérez, Loipa;
    • Santiesteban González, Yanela;
    • García Fernández, Lázara;
    • Regueiro Rodríguez, Lorena;
    • Macías Abrahan, Amparo;
    • Labrada Mon, Mayrel;
    • León Monzón, Kalet;
    • Saavedra Hernández, Danay;
    • Crombet Ramos, Tania
    Publication type:
    Article
    49
    50